ASC41 Tablets

· Gannex Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC41 Tablets, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH [Phase 2]